Results 191 to 200 of about 82,677 (285)

Impact of Blood Pressure Across the Life Course on Arterial Stiffness in Midlife: The Mediating Role of Metabolic Factors

open access: yesMedComm, Volume 6, Issue 11, November 2025.
This 30‐year cohort study demonstrates that elevated blood pressure (BP) since childhood contributes to arterial stiffness in midlife, with adult BP showing the strongest association. The triglyceride–glucose index partially mediates this relationship, especially in males. These findings highlight the importance of early BP control and metabolic health
Yang Wang   +25 more
wiley   +1 more source

Nicorandil in preventing contrast-induced nephropathy in patients undergoing cardiac catheterization procedures: a systematic review and meta-analysis. [PDF]

open access: yesAnn Med Surg (Lond)
Waseem R   +14 more
europepmc   +1 more source

Blockade of cannabinoid CB1 receptors potentiates the anti‐fibrotic effects mediated by SGLT2 inhibition in a mouse model of diabetic nephropathy

open access: yesBritish Journal of Pharmacology, Volume 182, Issue 21, Page 5355-5377, November 2025.
Background and purpose Diabetic nephropathy (DN) is a common complication of diabetes. Current treatments include renin‐angiotensin‐aldosterone system (RAAS) blockers and sodium‐glucose co‐transporter 2 (SGLT2) inhibitors. The cannabinoid CB1 receptor is a potential therapeutic target.
Océane Pointeau   +20 more
wiley   +1 more source

Contrast-Induced Nephropathy (CIN) After Invasive Treatment of Acute Coronary Syndromes-Predictors, Short and Long-Term Outcome. [PDF]

open access: yesJ Clin Med
Sielski J   +11 more
europepmc   +1 more source

SGLT2 inhibitor therapy and lower incidence of iron deficiency anaemia in patients with type 2 diabetes: A retrospective cohort study from Germany

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 11, Page 6559-6566, November 2025.
Abstract Aims Iron deficiency anaemia (IDA) is a common comorbidity in patients with type 2 diabetes mellitus (T2DM). Sodium–glucose cotransporter‐2 inhibitors (SGLT2i) have been shown to modulate erythropoiesis and iron metabolism, but their association remains unclear.
Theresia Sarabhai, Karel Kostev
wiley   +1 more source

Home - About - Disclaimer - Privacy